0 likes | 6 Views
Analysis of Liquid Pediatric Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~8% during 2024-2036 and Attain ~USD 20 Billion by 2036<br>
E N D
Analysis of Liquid Pediatric Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~8% during 2024-2036 and Attain ~USD 20 Billion by 2036 Research Nester assesses the growth and market size of global liquid pediatric market which is anticipated to be on account of the increasing demand from end-use industries and increasing demand for healthcare sector. New York – December 26, 2023 - Research Nester’s recent market research analysis on “Liquid Pediatric Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global liquid pediatric market in terms of market segmentation by type, end user, and by region.
Regulatory Emphasis on Pediatric Formulations to Promote Global Market Share of Liquid Pediatric The pharmaceutical landscape has witnessed a heightened emphasis on pediatric drug development, backed by regulatory initiatives globally. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), advocate for the development of pediatric-friendly formulations to address the unique needs of children. This regulatory focus encourages pharmaceutical companies to invest in research and development, driving innovation in liquid pediatric medications. Some of the major growth factors and challenges that are associated with the growth of the global liquid pediatric market are: Growth Drivers: • Increasing Awareness of Pediatric Health • Growing Prevalence of Pediatric Chronic Conditions Challenges: Ensuring accurate and consistent dosing is critical in pediatric care. However, the lack of standardized dosing instruments for liquid medications can lead to dosing errors, affecting the safety and efficacy of treatments. A study found that the use of different dosing instruments, such as cups, spoons, or droppers, contributed to dosing errors in pediatric patients. Standardizing dosing devices and providing clear instructions for use are crucial steps to address this challenge.
Access our detailed report at: https://www.researchnester.com/reports/liquid-pediatric-mark et/5504 The emulsion segment is to garner a highest revenue by the end of 2036 by growing at a significant CAGR over the forecast period. A crucial driver for the growth of emulsions in the liquid pediatric market is the increased preference for palatable formulations, especially among pediatric patients. Emulsions offer a versatile platform for incorporating flavors, enhancing taste appeal and ensuring better acceptance by children. This is particularly important in promoting adherence to medication regimens, especially for chronic conditions. A study found that the palatability of liquid medications significantly influences pediatric adherence. Emulsions, with their ability to mask the taste of active ingredients, were associated with higher rates of medication compliance among children. This underscores the importance of palatability in driving the growth of the emulsions segment. By region, the Europe liquid pediatric market is to generate a notable revenue by the end of 2036. Regulatory bodies in Europe, such as the European Medicines Agency (EMA), actively support pediatric drug development through initiatives and guidelines. The Pediatric Regulation, implemented in 2007, encourages research into pediatric formulations and ensures the availability of safe and effective medicines for children. As of 2020, the EMA reported that the Pediatric Regulation has led to an increase in the number of authorized pediatric medicines. Over 260 new pediatric indications were granted by the EMA since the implementation of
the regulation, indicating a positive regulatory environment for pediatric drug development. This report also provides the existing competitive scenario of some of the key players of the global liquid pediatric market which includes company profiling of Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Merck & Co., Inc.,and others. Request Report Sample@ https://www.researchnester.com/sample-request-5504 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919